Mental disorders increase risk of dementia later in life
By
Amy Novotney
Feb 17, 2022
Preventing and treating mental health disorders earlier in life might reduce or delay the risk of cognitive decline, according to a new study.
Heart attack survivors may be less likely to develop Parkinson’s disease
By
Amy Novotney
Feb 17, 2022
One-year survivors of a heart attack appear to be slightly less likely to develop Parkinson’s disease later in life. That’s according to a new study examining health registries from the Danish National...
Clinical briefs for Thursday, Feb. 17
By
Amy Novotney
Feb 17, 2022
More stewardship strategies linked to fewer discharge antibiotics … Memory retrieval problems may be due to knowledge clutter in older age: study … Impaired nasal cavity cells may explain early loss...
Antipsychotic reduction in LTC leads to drug substitutions, more delusions diagnoses
By
Alicia Lasek
Feb 16, 2022
Antipsychotic reduction in long-term care facilities likely results in significant unintended fallout, new data from Canada show. The results mirror those of similar studies in the United States, with...
Validating fears helps shift patients’ palliative care expectations: study
By
Alicia Lasek
Feb 16, 2022
Patients and family members are better able to consider end-of-life care recommendations when their healthcare provider focuses on changing expectations rather than on changing emotions, researchers have...
Switch to race-neutral equation would affect millions of U.S. kidney patients: study
By
Alicia Lasek
Feb 16, 2022
A highly recommended transition away from race-based measurements of kidney function resulted in new kidney disease classifications for 5.5 million patients in an analysis of 39,000, investigators say.
Clinical briefs for Wednesday, Feb. 16
By
Alicia Lasek
Feb 16, 2022
Impaired nasal cavity cells may explain early loss of smell in Alzheimer’s … COVID-19 cases fall by 40% across U.S.; virus hangs on in certain areas … Senate narrowly confirms Robert Califf to lead...
FDA authorizes monoclonal antibody that tackles omicron
By
Alicia Lasek
Feb 15, 2022
Bebtelovimab is greenlit for treatment of mild to moderate COVID-19 in patients at high risk of severe disease. The move comes amid a federal push to increase supply of effective therapies.
CDC: Coronavirus booster protection fades after 4 months
By
Alicia Lasek
Feb 15, 2022
Two new studies highlight the need to keep up with recommended vaccinations — especially for older adults.
Clinical briefs for Tuesday, Feb. 15
By
Alicia Lasek
Feb 15, 2022
Medicare telehealth waivers could get two-year extension … COVID-19 vaccines are a ‘freaking miracle’: Opinion … Antiviral pills are in stores, yet lack takers … HHS awards $55 million to boost...